Owned by the Association for International Promotion & Study in Tumors (APSIT)
Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer
Ropivacaine, a local anesthetic, exhibits anti-tumor effects in various cancer types. However, its specific functions and the molecular mechanisms involved in breast cancer cell stemness remain elusive.